Galletta Christopher 4
4 · Trevi Therapeutics, Inc. · Filed Apr 15, 2021
Insider Transaction Report
Form 4
Galletta Christopher
See Remarks
Transactions
- Award
Stock Option (right to buy)
2021-04-13+25,000→ 25,000 totalExercise: $2.53Exp: 2031-04-12→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option was granted on April 13, 2021. The 25,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on April 12, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter, through April 12, 2025.